27th National Clinical Education Symposium Presentation Abstracts

Actions for Presentation

Download PDF Back to list

Other presentations

The Ties Between Stress, Rumination, and Resilience in Physicians - Page S106
Nilgün Oktar Erdoğan, İbrahim Mert Erdoğan

Unipolar Mania and Bipolar Disorder: Evaluation from Obssesive Beliefs and Impulsivity Perspective - Page S107
Ecem Aydın, Batuhan Gülırmak, Özge Şahmelikoğlu Onur

Evaluation Of Mental And Cognitive Symptoms And Perceived Social Support In Mothers Of Children With Mental Disabilities - Page S108
Şuheda Tapan Çelikkaleli, Mustafa Akın, Pinar Guzel Ozdemir

Investigating the Risk and Protective Factors Determining Occupational Burnout Level of Hospital Staff in Periods of Crisis - Page S109
TALAT DEMİRSÖZ, MEVHIBE IREM YILDIZ

Evaluation of the Relationship Between Neutrophil/Lymphocyte, Platelet/Lymphocyte and Monocyte/Lymphocyte Ratios and the Type of Mood Disorder in Patients Presenting to the Psychiatry Outpatient Clinic During a Depressive Episode - Page S110
Hacer Reyyan Demirel, Şeyda Nur İspir Çaltıner, Fatih Ekici

Analysis of Supreme Court Decisions Regarding Post-Traumatic Stress Disorder from a Mental Health Perspective - Page S111
Buket Doğan, Ayşe Erdoğan Kaya

29 APRIL 2025, TUESDAY
17.00-18.15 ORAL PRESENTATION SESSION - 9

Evaluation of Sociodemographic Characteristics, Disease Characteristics and Treatments of Bipolar Disorder

Gökçe Kavak Sinanoğlu1

1. Alanya Education and Research Hospital

DOI: 10.5080/kes27.abs81 Page 105

BACKGROUND AND AIM:In the current treatment guidelines, single drug treatment is recommended for the treatment of BD, and combination treatments are frequently used in clinical practice. This study aimed to retrospectively determine psychotropic drug use in the long-term follow-up of BD patients and to investigate its place in daily clinical practice by correlating it with the sociodemographic and disease characteristics of the patients.
METHODS (Ethics Committee Approval must be obtained and the number should be specified.):The sociodemographic, disease-related characteristics and medications used by 141 patients followed up with the diagnosis of BD in ALKÜ were retrospectively examined. ALKÜ ethics committee approval was received dated 22.01.2025 and numbered 02-12
RESULTS:82 (58.2%) of the patients were female, mean age was 35.64±11.77 years. 47.5% of the patients were married and 44% were working. The age of onset of BD was 24.99±10.19. 51.8% of the patients had a family history of BD. The first illness period was determined to be mania in 41.1% (n: 58) of the patients and depression in 52.5% (n: 74). The first illness episode of 44.7% (n: 63) of the patients was psychotic. In their first episode, 17% of the patients were treated with a combination of mood stabilizers (MS) and antipsychotics (AP), and 19.9% (n: 28) were treated with only AP monotherapy. In their current treatments, 73% of the patients were treated with a combination of MS and AP.
CONCLUSIONS:The recommended treatment for BD is to use MS or AP the disease periods and to continue the treatment with only MS during the remission periods. However, it has been stated that in recent years, the use of AP has increased and the duration of use has been extended, both as AP, AD and MS. In a similar study, it was determined that 95.4% of patients used AP and MS in their treatment.